首頁 > 市場調查報告書 > 製藥

生物標記

市場調查報告書

商品編碼

1896860

數位生物標記市場規模、佔有率和成長分析（按類型、臨床實踐、治療領域、最終用戶和地區分類）：產業預測（2026-2033 年）

Digital Biomarkers Market Size, Share, and Growth Analysis, By Type, By Clinical Practice, By Therapeutic Area, By End Users, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月17日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，全球數位生物標記市場規模將達到 50.2 億美元，到 2025 年將成長至 64.7 億美元，到 2033 年將成長至 489.7 億美元，在預測期（2026-2033 年）內複合年成長率為 28.8%。

全球數位生物標記市場正經歷顯著成長，這主要得益於遠距照護服務和遠端患者監護需求的不斷成長。醫療技術的快速發展、創新解決方案的高普及率以及醫療費用支出的持續成長進一步推動了市場發展。分散式臨床試驗的投資和治療應用的拓展是關鍵促進因素，而穿戴式裝置和智慧型手機的廣泛應用也為此提供了有力支撐。監測呼吸、語音、體溫和眼動等指標的先進技術能夠實現複雜疾病的即時追蹤。音頻數位生物標記尤其展現出巨大的成長潛力。隨著智慧型手機和穿戴式裝置的普及，這些數位工具能夠透過語音錄製進行非侵入性採樣，這不僅提升了患者的便利性，也推動了智慧型手錶和健身追蹤器的普及。

全球數位生物標記市場促進因素

糖尿病、高血壓和心血管疾病的日益增多表明，醫療保健領域對數位生物標記的需求日益成長。這些創新工具能夠提供關鍵訊息，使醫療保健系統能夠快速回應並持續監測慢性疾病。透過促進最佳管理策略，數位生物標記有助於患者更長時間地保持健康，並減少住院次數。這不僅提高了個人的生活品質，還降低了醫療成本。因此，在對更有效的慢性疾病管理和改善患者預後的需求驅動下，全球數位生物標記市場正在蓬勃發展。

限制全球數位生物標記市場的因素

全球數位生物標記市場面臨許多挑戰，其中許多數位生物標記缺乏臨床檢驗，而臨床驗證對於其被接受並整合到標準醫療實踐中至關重要。缺乏嚴謹的檢驗引發了人們對其準確性和可靠性的擔憂，阻礙了醫療專業人員對其的信任。由於醫療專業人員在決策中優先考慮實證工具，缺乏檢驗的數位生物標記限制了他們採用這些技術的意願。因此，在缺乏必要的真實世界檢驗和療效證明的情況下，數位生物標記的廣泛接受和納入常規治療通訊協定仍然受到限制。

全球數位生物標記市場趨勢

全球數位生物標記市場正呈現出人工智慧 (AI) 技術融合的顯著趨勢，這正在改變穿戴式裝置和應用程式生成的健康數據的分析方式。這項進步使得透過先進的 AI 演算法處理大量患者資料成為可能，從而挖掘出傳統方法可能忽略的模式和洞見。因此，市場正朝著更積極主動和個人化的醫療保健解決方案轉型，以改善疾病管理並最佳化患者預後。利用數位生物標記的預測能力，醫療保健提供者能夠提供更精準的診斷和個人化的治療方案，有助於建立更有效率的醫療保健生態系統。

BioSensics（美國）
AliveCor（美國）
BACtrack（美國）
Eyenuk（美國）
Quibim（西班牙）
Biofourmis（美國）
Fitbit（美國）
Evidation Health（美國）
Empatica（美國）
飛利浦醫療保健（荷蘭）
美敦力（愛爾蘭）
Akili Interactive（美國）
蘋果公司（美國）
Biotricity（美國）
Tempus（美國）
Pear Therapeutics（美國）
BioBeats（英國）
Oura Health（芬蘭）
ActiGraph（美國）
科內克薩（美國）

結論與建議

簡介目錄

Product Code: SQMIG35G2218

Global Digital Biomarkers Market size was valued at USD 5.02 Billion in 2024 and is poised to grow from USD 6.47 Billion in 2025 to USD 48.97 Billion by 2033, growing at a CAGR of 28.8% during the forecast period (2026-2033).

The global digital biomarkers market is experiencing significant growth driven by rising demand for telecare services and remote patient monitoring. The swift advancement of healthcare technology, coupled with high adoption rates of innovative solutions and increasing healthcare spending, further boosts market momentum. Investment in decentralized clinical trials and the expansion of therapeutic applications are key factors, alongside the proliferation of wearable devices and smartphones. Advanced technologies that monitor indicators such as breathing, voice, temperature, and eye movements enable real-time tracking of complex diseases. Notably, vocal digital biomarkers show considerable potential for growth. With the widespread use of smartphones and wearables, these digital tools facilitate unobtrusive sampling through audio recordings, enhancing patient convenience while fostering the adoption of smartwatches and fitness trackers.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Digital Biomarkers market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Digital Biomarkers Market Segments Analysis

Global Digital Biomarkers Market is segmented by Type, Clinical Practice, Therapeutic Area, End Users and region. Based on Type, the market is segmented into Wearable, Mobile based Applications, Sensors and Others. Based on Clinical Practice, the market is segmented into Diagnostic digital biomarkers, Monitoring digital biomarkers, Predictive and Prognostic digital biomarkers and Others. Based on Therapeutic Area, the market is segmented into Cardiovascular and metabolic disorders (CVMD), Respiratory disorders, Psychiatric disorders, Sleep & Movement Disease, Neurological disorders, Musculoskeletal disorders and Others. Based on End Users, the market is segmented into Healthcare companies, Healthcare Providers, Payers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Digital Biomarkers Market

The increasing prevalence of diabetes, hypertension, and cardiovascular diseases highlights the rising need for digital biomarkers in healthcare. These innovative tools provide essential insights that enable healthcare systems to react promptly and maintain continuous monitoring of chronic conditions. By promoting optimal management strategies, digital biomarkers empower patients to maintain better health for extended durations, reducing the frequency of hospitalizations. This ultimately enhances the quality of life for individuals while simultaneously lowering healthcare costs. As a result, the global digital biomarkers market is gaining momentum, driven by the demand for more effective management of chronic diseases and improved patient outcomes.

Restraints in the Global Digital Biomarkers Market

The Global Digital Biomarkers market faces significant challenges due to the lack of clinical validation for many digital biomarkers, which is essential for their acceptance and integration into standard medical practices. This absence of rigorous research raises concerns about their accuracy and reliability, hindering trust among healthcare professionals. As medical practitioners prioritize evidence-based tools in their decision-making, the absence of validated digital biomarkers limits their willingness to adopt these technologies. Consequently, without the necessary validation and proven efficacy in real-world settings, the widespread acceptance and incorporation of digital biomarkers into routine treatment protocols remain constrained.

Market Trends of the Global Digital Biomarkers Market

The Global Digital Biomarkers market is witnessing a significant trend towards the integration of artificial intelligence (AI) technologies, transforming how health data generated from wearables and applications is analyzed. This advancement allows for the processing of vast amounts of patient data through sophisticated AI algorithms, unveiling patterns and insights that may go unnoticed by traditional methods. Consequently, the market is moving towards more proactive, personalized healthcare solutions, enhancing disease management capabilities and optimizing patient outcomes. By leveraging the predictive power of digital biomarkers, healthcare providers can deliver more accurate diagnoses and tailored treatment plans, fostering a more efficient healthcare ecosystem.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technology Analysis

Global Digital Biomarkers Market Size by Type & CAGR (2026-2033)

Market Overview
Wearable
Mobile based Applications
Sensors
Others

Global Digital Biomarkers Market Size by Clinical Practice & CAGR (2026-2033)

Market Overview
Diagnostic digital biomarkers
Monitoring digital biomarkers
Predictive and Prognostic digital biomarkers
Others

Global Digital Biomarkers Market Size by Therapeutic Area & CAGR (2026-2033)

Market Overview
Cardiovascular and metabolic disorders (CVMD)
Respiratory disorders
Psychiatric disorders
Sleep & Movement Disease
Neurological disorders
Musculoskeletal disorders
Others

Global Digital Biomarkers Market Size by End Users & CAGR (2026-2033)

Market Overview
Healthcare companies
Healthcare Providers
Payers
Others

Global Digital Biomarkers Market Size & CAGR (2026-2033)

North America (Type, Clinical Practice, Therapeutic Area, End Users)
- US
- Canada
Europe (Type, Clinical Practice, Therapeutic Area, End Users)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Clinical Practice, Therapeutic Area, End Users)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Clinical Practice, Therapeutic Area, End Users)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Clinical Practice, Therapeutic Area, End Users)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

BioSensics (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AliveCor (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BACtrack (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eyenuk (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quibim (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biofourmis (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fitbit (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Evidation Health (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Empatica (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Philips Healthcare (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Akili Interactive (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Apple Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biotricity (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tempus (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pear Therapeutics (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioBeats (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oura Health (Finland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ActiGraph (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Koneksa (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments